|
Characteristic
|
New T2D
|
Known T2D
|
P-value
|
|---|
|
Sex (n; male/female)
|
569/462
|
656/662
|
0.009
|
|
Age (years)
|
55.0 ± 12.0
|
58.7 ± 10.8
|
< 0.001
|
|
BMI (kg/m2)
|
29.9 ± 5.2
|
30.5 ± 5.5
|
0.009
|
|
Waist (cm)
|
103 ± 13
|
104 ± 14
|
0.009
|
|
Systolic BP (mmHg)
|
136 ± 17
|
135 ± 17
|
0.103
|
|
Diastolic BP (mmHg)
|
78 ± 10
|
75 ± 9
|
< 0.001
|
|
Heart rate (bpm)
|
73 ± 12
|
74 ± 12
|
0.827
|
|
Creatinine (μmol/l)
|
75 ± 16
|
74 ± 17
|
0.052
|
|
eGFR (ml/min/1.73m2)
|
90 ± 16
|
88 ± 17
|
0.003
|
|
Total cholesterol (mmol/l)
|
5.3 ± 1.2
|
4.5 ± 1.0
|
< 0.001
|
|
HDL-cholesterol (mmol/l)
|
1.26 ± 0.36
|
1.27 ± 0.36
|
0.433
|
|
LDL-cholesterol (mmol/l)
|
3.4 ± 1.0
|
2.7 ± 0.9
|
< 0.001
|
|
Triacylglycerol (mmol/l)
|
1.88 ± 1.30
|
1.70 ± 1.11
|
< 0.001
|
|
Glucose (mmol/l)
|
7.6 ± 2.3
|
7.6 ± 2.1
|
0.747
|
|
HbA1c (mmol/mol)
|
49 ± 14
|
52 ± 11
|
< 0.001
|
|
HbA1c (%)
|
6.7 ± 1.2
|
6.9 ± 1.0
|
< 0.001
|
|
Current smoking (%)
|
23.7
|
14.4
|
< 0.001
|
|
Former smoking (%)
|
42.5
|
51.1
|
< 0.001
|
|
% w. BP-lowering therapy
|
35.7
|
63.4
|
< 0.001
|
|
% w. statins
|
20.1
|
63.0
|
< 0.001
|
|
Skin autofluorescence (AU)
|
2.25 ± 0.50
|
2.42 ± 0.54
|
< 0.001
|
|
SAF z score
|
0.34 ± 0.89
|
0.56 ± 0.99
|
< 0.001
|
- Data are presented as mean ± SD, number or %
